Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Health Catalyst (HCAT) Depreciation & Amortization (IS) (2018 - 2025)

Health Catalyst's Depreciation & Amortization (IS) history spans 8 years, with the latest figure at $12.9 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 25.48% year-over-year to $12.9 million; the TTM value through Dec 2025 reached $50.5 million, up 21.89%, while the annual FY2025 figure was $50.5 million, 21.89% up from the prior year.
  • Depreciation & Amortization (IS) reached $12.9 million in Q4 2025 per HCAT's latest filing, up from $12.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $12.9 million in Q4 2025 to a low of $7.8 million in Q1 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $11.0 million, with a median of $10.8 million recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization (IS): surged 171.6% in 2021, then decreased 17.64% in 2023.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $10.9 million in 2021, then grew by 6.77% to $11.7 million in 2022, then decreased by 11.66% to $10.3 million in 2023, then decreased by 0.37% to $10.3 million in 2024, then grew by 25.48% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Depreciation & Amortization (IS) are $12.9 million (Q4 2025), $12.6 million (Q3 2025), and $12.7 million (Q2 2025).